Services
Genomic Testing
Companion Diagnostic Test
Laboratory Developed Tests (LDT)
Solid Tumors
Hematologic Malignancies
Hereditary Cancers
Minimal Residual Disease
RUO Kit Solution
Research Services
Platforms
DNA Sequencing
RNA Sequencing
Other Services
Technology
Our Technology
Publications
Partnerships
About Us
What is Precision Oncology?
Our Company
Our Team
Certificates & Accreditation
News
Join Us
Contact Us
Ch|中文
Search
November 3, 2022
Geneseeq study evaluates the clinical value of cell-free DNA 5’-end motif profile in the prediction of pathological complete response for LARC patients after neoadjuvant chemoradiotherapy
by Geneseeq
Privacy Preference Center
Privacy Preferences